Ankit Lodaya | Senior Director Pharmacovigilance
Bluebird Bio

Ankit Lodaya, Senior Director Pharmacovigilance, Bluebird Bio

Accomplished pharmacovigilance professional with more than 16 years of experience. Have successfully led teams both as a vendor and as a sponsor. I have been the lead PV scientist for two gene therapy approvals and have enjoyed communicating with the FDA; also preparing and part-taking at the first advisory committee for a gene therapy for beta-thalassemia and am leading commercial gene therapy programs with ongoing clinical development. I have learnt a lot, achieved professional growth and made friends while working at Ironwood pharmaceuticals, Biogen and bluebird bio where i have held positions in varied capacities and responsibilities. In my cumulative work experience, I have gained expertise in safety monitoring as well as operational activities related to clinical trials, regulatory approvals, labeling, commercial use as well as registry set-up. I feel grateful working as a pharmacovigilance professional and striving to ensure patient safety.

Appearances:



Day 1 - World Drug Safety Congress Americas 2025 @ 12:00

Presentation: From Clinical to Commercial: Safety Monitoring for Rare Gene Therapies

last published: 27/Jun/25 19:45 GMT

back to speakers

Get Involved At Drug Safety Congress Americas

 

CONNECT WITH US

 

For Sponsorship and Exhibition opportunities

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

 

To Speak
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

 

Marketing & Press
Opportunities

Karen Duncan
karen.duncan@terrapinn.com